Aurora Cannabis Inc. (NYSE: ACB) Q1 2021 earnings call dated Nov. 09, 2020 Corporate Participants: Miguel Martin -- Chief Executive Officer Glen Ibbott -- Chief Financial
Aurora Cannabis Inc.
-(ACB)
XNAS:ACB
Infographic: Highlights of Aurora Cannabis’ (ACB) Q1 2021 earnings report
Aurora Cannabis, Inc. (NYSE: ACB) reported a loss for the first quarter of 2021, continuing the recent trend. However, the bottom-line performance
Earnings calendar for the week of Nov. 9
Taking a cue from the presidential election, stock markets bounced back after ending the previous week on a low note. Major indexes
Aurora Cannabis (ACB) banks on premium brands after disastrous Q4
Shareholders of Aurora Cannabis (NYSE: ACB) were dealt an unexpected blow this week as the pot company's disappointing earnings report thwarted hopes
Aurora Cannabis Inc. (ACB) Q4 2020 Earnings Call Transcript
Aurora Cannabis Inc (NYSE: ACB) Q4 2020 earnings call dated Sep. 22, 2020 Corporate Participants: Miguel Martin -- Chief Executive Officer and Chief Commercial
Highlights of Aurora Cannabis (ACB) Q4 2020 earnings report
Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues.
Aurora Cannabis Inc (NYSE: ACB) Q3 2020 Earnings Call Transcript
Aurora Cannabis Inc (ACB) Q3 2020 earnings call dated May 14, 2020 Corporate Participants: Michael Singer -- Executive Chairman and Interim Chief Executive Officer
Infographic: Highlights of Aurora Cannabis (ACB) Q3 2020 Earnings Report
Aurora Cannabis, Inc. (NYSE: ACB) reported a narrower loss for the third quarter of 2020, aided by a 16% growth in revenues.
Aurora Cannabis Inc (NYSE: ACB) Q2 2020 Earnings Call Transcript
Aurora Cannabis Inc (NYSE: ACB) Q2 2020 Earnings Conference Call February 13, 2020 Corporate Participants: Michael Singer -- Interim Chief Executive Officer and Executive
Aurora Cannabis (ACB) reports wider Q2 loss; launches Cannabis 2.0 in Canada
For Aurora Cannabis, Inc. (NYSE: ACB), the last few months have been momentous, marked by key organizational changes including an executive reshuffle.
Earnings preview: Aurora Cannabis (ACB) likely to post a narrower loss in Q2
Aurora Cannabis Inc. (NYSE: ACB) is slated to report its second-quarter 2020 on Thursday before the market opens. The top line will
Aurora Cannabis’ stock tanks amid new corporate developments
Shares of Aurora Cannabis (NYSE: ACB) fell over 8% in morning trade on Monday as the company announced several updates from the
Cannabis stocks: Major players see a pickup amid FDA warnings
The stocks of major cannabis companies appear to be picking up after seeing a drop following FDA warnings over the safety of
Aurora Cannabis (NYSE: ACB) Q1 profit dips 90% but beats estimates
Aurora Cannabis Inc. (NYSE: ACB) reported a 154% jump in revenues for the first quarter of 2020 helped by higher cannabis production
Aurora Cannabis (ACB) earnings preview: What to look for in Q1 report
Aurora Cannabis, Inc. (NYSE: ACB) is all set to publish its first-quarter results Thursday after the closing bell. The company continues to
Aphria, Canopy Growth, Aurora Cannabis bow to pressure from vaping fatalities
Leading players in the cannabis industry were bleeding on Monday after the Centers for Disease Control and Prevention (CDC) revealed that it
Aurora, Canopy Growth to be the biggest gainers in Cannabis 2.0
Both Aurora Cannabis (NYSE: ACB) and Canopy Growth Corporation (NYSE: CGC) have reported disappointing quarterly results in the most recent quarter. Share
Aurora Cannabis stock drops after reporting Q4 results
Aurora Cannabis (NYSE: ACB) reported fourth quarter 2019 results and the topline missed the company's estimates. ACB stock, which closed up 3.34%
What to expect from Aurora Cannabis Q4 earnings
Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB) is slated to report its fourth-quarter results on September 11 after the bell followed by
Pot giants gain on DEA announcement; GW Pharmaceuticals continues to decline
Marijuana giants received a major boost on Monday after the US Drug Enforcement Administration (DEA) announced that it would initiate steps to
DEEP FOCUS: Everything you need to know about GW Pharmaceuticals
Shares of GW Pharmaceuticals (NASDAQ: GWPH) have gained 72% in the year-to-date period, emerging as a new favorite among pot investors. However,